|
|
|
|
LEADER |
03105nam a22005295i 4500 |
001 |
978-0-387-24199-9 |
003 |
DE-He213 |
005 |
20151204190150.0 |
007 |
cr nn 008mamaa |
008 |
100301s2005 xxu| s |||| 0|eng d |
020 |
|
|
|a 9780387241999
|9 978-0-387-24199-9
|
024 |
7 |
|
|a 10.1007/b104814
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a RC254-282
|
072 |
|
7 |
|a MJCL
|2 bicssc
|
072 |
|
7 |
|a MED062000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.994
|2 23
|
245 |
1 |
0 |
|a Leptomeningeal Metastases
|h [electronic resource] /
|c edited by Lauren E. Abrey, Marc C. Chamberlain, Herbert H. Engelhard.
|
264 |
|
1 |
|a Boston, MA :
|b Springer US,
|c 2005.
|
300 |
|
|
|a VII, 196 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
490 |
1 |
|
|a Cancer Treatment and Research,
|x 0927-3042 ;
|v 125
|
505 |
0 |
|
|a Anatomy and Physiology of the Leptomeninges and CSF Space -- Leptomeningeal Neoplasia: Epidemiology, Clinical Presentation, CSF Analysis and Diagnostic Imaging -- Leptomeningeal Metastases from Solid Tumors (Meningeal Carcinomatosis) -- Leptomeningeal Metastases from Leukemias and Lymphomas -- Leptomeningeal Metastasis of Primary Central Nervous System (CNS) Neoplasms -- Leptomeningeal Cancer in the Pediatric Patient -- Neurosurgical Interventions for Leptomeningeal Tumor -- Current Treatment of Leptomeningeal Metastases: Systemic Chemotherapy, Intrathecal Chemotherapy and Symptom Management -- Radiation Therapy for Leptomeningeal Cancer -- Animal Models of Leptomeningeal Cancer -- Improving the Outcome of Patients with Leptomeningeal Cancer: New Clinical Trials and Experimental Therapies.
|
520 |
|
|
|a Leptomeningeal Metastases provides the reader with an overview of the state-of-the-art therapy for the leptomeningeal patient with additional information on epidemiology, symptom management, new clinical trials, and current basic research in animal models for experimental therapies. "Leptomeningeal metastases remains a devastating manifestation of hematologic malignancies and solid tumors. Leading figures in the field review the pathophysiology and clinical consequences of this process. State-of-the-art treatment strategies are presented highlighting advances in current management." Steven T. Rosen, M.D. Series Editor.
|
650 |
|
0 |
|a Medicine.
|
650 |
|
0 |
|a Oncology.
|
650 |
|
0 |
|a Neurology.
|
650 |
|
0 |
|a Neurosurgery.
|
650 |
|
0 |
|a Surgical oncology.
|
650 |
1 |
4 |
|a Medicine & Public Health.
|
650 |
2 |
4 |
|a Oncology.
|
650 |
2 |
4 |
|a Neurology.
|
650 |
2 |
4 |
|a Neurosurgery.
|
650 |
2 |
4 |
|a Surgical Oncology.
|
700 |
1 |
|
|a Abrey, Lauren E.
|e editor.
|
700 |
1 |
|
|a Chamberlain, Marc C.
|e editor.
|
700 |
1 |
|
|a Engelhard, Herbert H.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9780387241982
|
830 |
|
0 |
|a Cancer Treatment and Research,
|x 0927-3042 ;
|v 125
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/b104814
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SME
|
950 |
|
|
|a Medicine (Springer-11650)
|